C2N Diagnostics News and Activities
Executives
View the org chart displaying its 25 main executives
Most searched biographies at C2N Diagnostics
- Joel Braunstein, President and Chief Executive Officer
- David Holtzman, Director
- Randall Bateman, Director
Create your alert
to follow the executive moves at C2N Diagnostics.
Biotechnology
C2N Diagnostics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
- NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
- Rallybio and Avenzo Therapeutics have announced they will merge (posted on June 1 2026)..
Popular contacts in Biotechnology
News
Press releases by C2N Diagnostics
- News Releases — C2N Diagnostics
- C2N Diagnostics Notice of Cybersecurity Incident — C2N Diagnostics
- News Releases — C2N Diagnostics
- C2N HIGHLIGHTS FIRST USE OF ITS eMTBR-TAU243 PLASMA ASSAY IN EVOKE/EVOKE+ PHASE 3 DATASET FOR PREDICTION OF COGNITIVE AND FUNCTIONAL DECLINE IN PATIENTS WITH EARLY SYMPTOMATIC AD — C2N Diagnostics
- News Releases — C2N Diagnostics
- C2N Diagnostics Enters South Korean Market Through Partnership withBeauBrain Healthcare to Offer Precivity™ Portfolio of Blood Tests toHelp Doctors Diagnose Alzheimer’s Disease — C2N Diagnostics
- News Releases — C2N Diagnostics
- C2N Diagnostics Awarded Rigorous New York State Department of Health Permit, Expanding Ability to Provide Its Blood Tests toHelp Diagnose Alzheimer’s Disease — C2N Diagnostics
- C2N Diagnostics and WashU Medicine Teams Receive Prestigious Award from Human Proteome Organization — C2N Diagnostics
- News Releases — C2N Diagnostics
- View more press releases Close
Social media about C2N Diagnostics
- C2N Diagnostics on Wikipedia, Google News & Yahoo Finance
- C2N Diagnostics on LinkedIn, X (Twitter) & YouTube
